ANDA 70820, held by Am Regent. Dopamine Hydrochloride.
As of Nov 16, 2026, ANDA 70820 (Dopamine Hydrochloride), held by Am Regent, was first approved by FDA on Feb 11, 1987, with 12 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 11, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dopamine Hydrochloride80MG/ML · injectable;injection | Dopamine Hydrochloride | Discontinued |
| Jun 21, 2021 | Supplement 17Labeling · Standard review | Approved | None posted |
| Nov 7, 2001 | Supplement 11Labeling | Approved | None posted |
| Jan 9, 1998 | Supplement 9Manufacturing | Approved | None posted |
| Nov 7, 1997 | Supplement 10Labeling | Approved | None posted |
| Sep 24, 1996 | Supplement 8Labeling | Approved | None posted |
| Feb 28, 1996 | Supplement 7Manufacturing | Approved | None posted |
| Jun 30, 1993 | Supplement 6Manufacturing | Approved | None posted |
| Oct 27, 1992 | Supplement 5Labeling | Approved | None posted |
| Aug 26, 1992 | Supplement 4Labeling | Approved | None posted |
| Feb 5, 1992 | Supplement 2Manufacturing | Approved | None posted |
| Jun 30, 1989 | Supplement 3Manufacturing | Approved | None posted |
| Jun 30, 1989 | Supplement 1Manufacturing | Approved | None posted |
| Feb 11, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters